Format

Send to

Choose Destination
Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e01524-17. doi: 10.1128/AAC.01524-17. Print 2017 Sep.

Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis".

Author information

1
University of Florida College of Pharmacy and Emerging Pathogens Institute, Gainesville, Florida, USA.
2
Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.
3
Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
4
Socios En Salud, Lima, Peru.
5
Hospital Nacional Sergio Bernales, Lima, Peru.
6
Hospital Nacional Hipólito Unanue, Lima, Peru.
7
Partners In Health, Boston, Massachusetts, USA.
8
Institutes of Infection and Global Health and Translational Medicine, University of Liverpool, Liverpool, United Kingdom.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center